•
Jun 30, 2023

3D Systems Q2 2023 Earnings Report

3D Systems reported a decrease in revenue due to lower sales in the dental orthodontics market, while also seeing growth in non-dental markets and investing in regenerative medicine.

Key Takeaways

3D Systems reported a decrease in revenue for Q2 2023, primarily due to lower sales in the dental orthodontics market. However, the company saw growth in non-dental markets and continued to invest in regenerative medicine. They are adjusting their full-year 2023 revenue expectation to $525 million to $545 million and anticipate positive adjusted EBITDA in Q4 2023.

Revenue decreased by 8.5% to $128.194 million compared to the same period last year, with a decrease of 8.7% on a constant currency basis.

The decline in revenue primarily reflects lower sales to certain dental orthodontic market customers due to macroeconomic factors.

Healthcare Solutions revenue decreased by 15.2% to $60.874 million compared to the same period last year, while Industrial Solutions revenue decreased by 1.4% to $67.320 million.

The company is adjusting its full-year 2023 revenue expectation to $525 million to $545 million and expects positive adjusted EBITDA in Q4 2023.

Total Revenue
$128M
Previous year: $140M
-8.5%
EPS
-$0.07
Previous year: -$0.07
+0.0%
Gross Profit
$50M
Previous year: $53.1M
-5.8%
Cash and Equivalents
$492M
Previous year: $638M
-23.0%
Free Cash Flow
-$23.1M
Previous year: -$29.4M
-21.5%
Total Assets
$1.43B
Previous year: $1.48B
-3.4%

3D Systems

3D Systems

3D Systems Revenue by Segment

Forward Guidance

3D Systems is revising its full-year 2023 revenue expectation to $525 million to $545 million, and would now expect positive adjusted EBITDA in Q4’23. This includes the full year investment of roughly $10 million in our regenerative medicine business.

Revenue & Expenses

Visualization of income flow from segment revenue to net income